Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 177

1.

Resveratrol as a Therapeutic Agent for Alzheimer's Disease.

Ma T, Tan M, Yu J, Tan L.

Biomed Res Int. 2014;2014:350516. Epub 2014 Nov 26. Review.

PMID:
25525597
[PubMed - as supplied by publisher]
2.

AMPK-dependent autophagic activation is probably involved in the mechanism of resveratrol exerting therapeutic effects for Alzheimer's disease.

Wang ZG, Yang C, Zhu B, Hua F.

Rejuvenation Res. 2014 Dec 14. [Epub ahead of print]

PMID:
25496421
[PubMed - as supplied by publisher]
3.

Capping of Aβ42 Oligomers by Small Molecule Inhibitors.

Fu Z, Aucoin D, Ahmed M, Ziliox M, Van Nostrand WE, Smith SO.

Biochemistry. 2014 Dec 11. [Epub ahead of print]

PMID:
25422864
[PubMed - as supplied by publisher]
4.

Nutraceuticals and amyloid neurodegenerative diseases: a focus on natural phenols.

Rigacci S, Stefani M.

Expert Rev Neurother. 2014 Nov 24:1-12. [Epub ahead of print]

PMID:
25418871
[PubMed - as supplied by publisher]
5.

Possible role of resveratrol targeting estradiol and neprilysin pathways in lipopolysaccharide model of Alzheimer disease.

El-Sayed NS, Bayan Y.

Adv Exp Med Biol. 2015;822:107-18. doi: 10.1007/978-3-319-08927-0_12.

PMID:
25416980
[PubMed - in process]
6.

Roles of resveratrol and other grape-derived polyphenols in Alzheimer's disease prevention and treatment.

Pasinetti GM, Wang J, Ho L, Zhao W, Dubner L.

Biochim Biophys Acta. 2014 Oct 12. pii: S0925-4439(14)00312-3. doi: 10.1016/j.bbadis.2014.10.006. [Epub ahead of print]

PMID:
25315300
[PubMed - as supplied by publisher]
7.

Neuroprotective effects of resveratrol in Alzheimer disease pathology.

Rege SD, Geetha T, Griffin GD, Broderick TL, Babu JR.

Front Aging Neurosci. 2014 Sep 11;6:218. doi: 10.3389/fnagi.2014.00218. eCollection 2014. Review.

PMID:
25309423
[PubMed]
Free PMC Article
8.

Interaction of Aβ(25-35) fibrillation products with mitochondria: Effect of small-molecule natural products.

Ghobeh M, Ahmadian S, Meratan AA, Ebrahim-Habibi A, Ghasemi A, Shafizadeh M, Nemat-Gorgani M.

Biopolymers. 2014 Nov;102(6):473-86. doi: 10.1002/bip.22572.

PMID:
25297917
[PubMed - in process]
9.

Alzheimer's disease and epigenetic diet.

Sezgin Z, Dincer Y.

Neurochem Int. 2014 Oct 5;78C:105-116. doi: 10.1016/j.neuint.2014.09.012. [Epub ahead of print] Review.

PMID:
25290336
[PubMed - as supplied by publisher]
10.

Neuroprotective action of resveratrol.

Bastianetto S, Ménard C, Quirion R.

Biochim Biophys Acta. 2014 Oct 2. pii: S0925-4439(14)00292-0. doi: 10.1016/j.bbadis.2014.09.011. [Epub ahead of print] Review.

PMID:
25281824
[PubMed - as supplied by publisher]
11.

Novel resveratrol analogues attenuate renal ischemic injury in rats.

Khader A, Yang WL, Kuncewitch M, Prince JM, Marambaud P, Nicastro J, Coppa GF, Wang P.

J Surg Res. 2015 Feb;193(2):807-15. doi: 10.1016/j.jss.2014.08.015. Epub 2014 Aug 13.

PMID:
25214260
[PubMed - in process]
12.

Resveratrol improves cognition and reduces oxidative stress in rats with vascular dementia.

Ma X, Sun Z, Liu Y, Jia Y, Zhang B, Zhang J.

Neural Regen Res. 2013 Aug 5;8(22):2050-9. doi: 10.3969/j.issn.1673-5374.2013.22.004.

PMID:
25206513
[PubMed]
Free PMC Article
13.

Neuroprotective role of trans-resveratrol in a murine model of familial Alzheimer's disease.

Porquet D, Griñán-Ferré C, Ferrer I, Camins A, Sanfeliu C, Del Valle J, Pallàs M.

J Alzheimers Dis. 2014;42(4):1209-20. doi: 10.3233/JAD-140444.

PMID:
25024312
[PubMed - in process]
14.

Supplemental substances derived from foods as adjunctive therapeutic agents for treatment of neurodegenerative diseases and disorders.

Bigford GE, Del Rossi G.

Adv Nutr. 2014 Jul 14;5(4):394-403. doi: 10.3945/an.113.005264. Print 2014 Jul. Review.

PMID:
25022989
[PubMed - in process]
15.

Successful therapies for Alzheimer's disease: why so many in animal models and none in humans?

Franco R, Cedazo-Minguez A.

Front Pharmacol. 2014 Jun 25;5:146. doi: 10.3389/fphar.2014.00146. eCollection 2014. Review.

PMID:
25009496
[PubMed]
Free PMC Article
16.

New multi-target-directed small molecules against Alzheimer's disease: a combination of resveratrol and clioquinol.

Mao F, Yan J, Li J, Jia X, Miao H, Sun Y, Huang L, Li X.

Org Biomol Chem. 2014 Aug 21;12(31):5936-44. doi: 10.1039/c4ob00998c.

PMID:
24986600
[PubMed - in process]
17.

Pinosylvin-mediated protection against oxidative stress in human retinal pigment epithelial cells.

Koskela A, Reinisalo M, Hyttinen JM, Kaarniranta K, Karjalainen RO.

Mol Vis. 2014 Jun 2;20:760-9. eCollection 2014.

PMID:
24940030
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Sirtuin modulators control reactive gliosis in an in vitro model of Alzheimer's disease.

Scuderi C, Stecca C, Bronzuoli MR, Rotili D, Valente S, Mai A, Steardo L.

Front Pharmacol. 2014 May 13;5:89. doi: 10.3389/fphar.2014.00089. eCollection 2014.

PMID:
24860504
[PubMed]
Free PMC Article
19.

Resveratrol and Alzheimer's disease: message in a bottle on red wine and cognition.

Granzotto A, Zatta P.

Front Aging Neurosci. 2014 May 14;6:95. doi: 10.3389/fnagi.2014.00095. eCollection 2014. Review.

PMID:
24860502
[PubMed]
Free PMC Article
20.

Fluorogenic resveratrol-confined graphene oxide for economic and rapid detection of Alzheimer's disease.

He XP, Deng Q, Cai L, Wang CZ, Zang Y, Li J, Chen GR, Tian H.

ACS Appl Mater Interfaces. 2014 Apr 23;6(8):5379-82. doi: 10.1021/am5010909. Epub 2014 Apr 8.

PMID:
24702005
[PubMed - in process]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk